UNSPSC 51262200: Adrenergic blocking agent dioxanes

This classification denotes adrenergic blocking agents made from 1,4-Diethylene dioxides.

UNSPSC 51262200 Adrenergic blocking agent dioxanes is a Class code that in recent state and local procurement maps to naloxone acquisition and related harm-reduction pharmaceutical products rather than the narrow pharmacological category the code name suggests. State and local health departments and emergency-response agencies are using this code to procure naloxone units and complementary drug-deactivation systems in support of opioid-emergency and community-health programs. The issuing bodies include county health systems and state health and human services commissions pursuing direct procurement of finished pharmaceuticals and related devices.

Recent activity centers in Florida and Texas. Seminole County, Florida issued IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building, Sanford, with response due July 26, 2023 (note: date appears inconsistent with posting date). The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capability information on direct-to-manufacturer prescription programs, exploring strategies for state procurement of pharmaceutical products outside traditional pharmacy benefit manager and group purchasing organization channels. Both solicitations reflect state and local interest in acquiring pharmaceuticals and related products through flexible contracting models that may include negotiated net pricing and direct manufacturer relationships.